| 2024 |
Thrombotic Risk and Calculated Whole Blood Viscosity in a Cohort of Patients With New Diagnosis of Multiple Myeloma |
Articolo in rivista |
Vai |
| 2024 |
Bone damage and health-related quality of life in Hodgkin lymphoma survivors: closing the gaps |
Review essay (rassegna critica) |
Vai |
| 2024 |
Vaccination strategies for patients with lymphoma treated in early lines of therapies: a real-world practice survey among Fondazione Italiana Linfomi centers |
Articolo in rivista |
Vai |
| 2024 |
Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study |
Articolo in rivista |
Vai |
| 2024 |
Changes in RDW according to prognostic predictors in newly diagnosed multiple myeloma |
Articolo in rivista |
Vai |
| 2023 |
Erythrocyte deformability profile evaluated by laser diffractometry in patients with multiple myeloma: Re-examination of our cases |
Articolo in rivista |
Vai |
| 2023 |
EBF1, MYO6 and CALR expression levels predict therapeutic response in diffuse large B-cell lymphomas |
Articolo in rivista |
Vai |
| 2023 |
Molecular-Biology-Driven Frontline Treatment for Chronic Lymphocytic Leukemia: A Network Meta-Analysis of Randomized Clinical Trials |
Articolo in rivista |
Vai |
| 2023 |
Calculated Whole Blood Viscosity and Albumin/Fibrinogen Ratio in Patients with a New Diagnosis of Multiple Myeloma: Relationships with Some Prognostic Predictors |
Articolo in rivista |
Vai |
| 2022 |
Host-related factors and cancer: Malnutrition and non-Hodgkin lymphoma |
Review essay (rassegna critica) |
Vai |
| 2022 |
Triple-Negativity Identifies a Subgroup of Patients with Better Overall Survival in Essential Thrombocythemia |
Articolo in rivista |
Vai |
| 2022 |
High Output Heart Failure in Multiple Myeloma: Pathogenetic Considerations |
Review essay (rassegna critica) |
Vai |
| 2022 |
Effects of B-Cell Lymphoma on the Immune System and Immune Recovery after Treatment: The Paradigm of Targeted Therapy |
Review essay (rassegna critica) |
Vai |
| 2022 |
Familial essential thrombocythemia: 6 cases from a mono‐institutional series |
Articolo in rivista |
Vai |
| 2021 |
Cardiovascular Issues in Tyrosine Kinase Inhibitors Treatments for Chronic Myeloid Leukemia: A Review |
Review essay (rassegna critica) |
Vai |
| 2021 |
Isolated Nodal TBC Reactivation in a Patient with Post-Thrombocythemia Myelofibrosis Treated with Ruxolitinib: Case Report and Review of the Literature |
Articolo in rivista |
Vai |
| 2021 |
Thrombotic risk in paroxysmal nocturnal hemoglobinuria-like (PNH-like) phenotype |
Review essay (rassegna critica) |
Vai |
| 2021 |
Prevention of venous thromboembolic events occurring in myeloma patients treated with second-generation novel agents |
Review essay (rassegna critica) |
Vai |
| 2021 |
Comparison between whole blood viscosity measured and calculated in subjects with monoclonal gammopathy of undetermined significance and in patients with multiple myeloma: Re-evaluation of our survey |
Articolo in rivista |
Vai |
| 2021 |
Bone damage after chemotherapy for lymphoma: a real-world experience |
Articolo in rivista |
Vai |
| 2020 |
Cardiovascular risk in polycythemia vera: Thrombotic risk and survival: Can cytoreductive therapy be useful in patients with low-risk polycythemia vera with cardiovascular risk factors? |
Articolo in rivista |
Vai |
| 2020 |
The difference of free light chains as a predictor of kidney damage in patients with Multiple Myeloma |
Articolo in rivista |
Vai |
| 2020 |
Coexistence of Von Willebrand disease and gastrointestinal stromal tumor (G.I.S.T): Case report of a rare and challenge association |
Lettera |
Vai |
| 2020 |
CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL |
Articolo in rivista |
Vai |
| 2020 |
Cardiovascular risk factor in MPN patients |
Lettera |
Vai |
| 2020 |
Clinical phenotype and response to different lines of therapy in elderly with immune thrombocytopenia: A retrospective study |
Articolo in rivista |
Vai |
| 2020 |
The Essential Thrombocythemia, Thrombotic Risk Stratification, and Cardiovascular Risk Factors |
Articolo in rivista |
Vai |
| 2020 |
The Essential Thrombocythemia in 2020: What We Know and Where We Still Have to Dig Deep |
Articolo in rivista |
Vai |
| 2019 |
Paroxysmal nocturnal hemoglobinuria-like phenotype and thrombotic risk in several clinical disorders |
Lettera |
Vai |
| 2019 |
MESENCHYMAL STEM CELLS IN PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS: IDLE OBSERVERS OR PART OF THE DISEASE? |
Abstract in atti di convegno pubblicato in rivista |
Vai |
| 2019 |
Acquired Hemophilia A Associated with Venous Thrombosis and Very High Inhibitor Titer: A Challenging Scenario |
Lettera |
Vai |
| 2019 |
Management of Ponatinib in Patients with Chronic Myeloid Leukemia with Cardiovascular Risk Factors |
Articolo in rivista |
Vai |
| 2019 |
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients |
Lettera |
Vai |
| 2019 |
Combined Point of Care Tools Are Able to Improve Treatment Adherence and Health-Related Quality of Life in Patients with Severe Hemophilia: An Observational Prospective Study |
Abstract in atti di convegno pubblicato in rivista |
Vai |
| 2019 |
Evaluation of Bone Marrow CD8+ tissue-Resident Memory T Cells in Multiple Myeloma |
Abstract in atti di convegno pubblicato in rivista |
Vai |
| 2019 |
Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system |
Articolo in rivista |
Vai |
| 2019 |
Antimicorbial prophylaxis in patients with immune thrombocytopenia treated with rituximab:a retrospective analysis |
Abstract in atti di convegno pubblicato in rivista |
Vai |
| 2019 |
Buffy coat-derived platelets cryopreserved using a new method: Results from a pivotal clinical trial on thrombocytopenic patients with acute leukaemia |
Articolo in rivista |
Vai |
| 2019 |
Comparison between thrombotic risk scores in Essential Thrombocythemia and survival implications |
Articolo in rivista |
Vai |
| 2018 |
Paroxysmal nocturnal haemoglobinuria: When delay in diagnosis and long therapy occurs |
Articolo in rivista |
Vai |
| 2018 |
Buffy coat-derived platelets cryopreserved using a new method: Results from in vitro studies |
Articolo in rivista |
Vai |
| 2018 |
Immunosenescence and lymphomagenesis |
Articolo in rivista |
Vai |
| 2018 |
Lymphomas and thyroid: Bridging the gap |
Articolo in rivista |
Vai |
| 2018 |
Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study |
Articolo in rivista |
Vai |
| 2017 |
Cardio-oncology in multiple myeloma: is it time for a specific focus? |
Articolo in rivista |
Vai |
| 2017 |
COMPARISON OF CLINICAL AND LABORATORY DATA, INCLUDING JAK-2 46/1 HAPLOTYPE, BETWEEN PATIENTS WITH IDIOPATHIC ERYTHROCYTOSIS AND POLYCYTHEMIA VERA. |
Abstract in atti di convegno pubblicato in rivista |
Vai |
| 2017 |
JAK2 ALLELE BURDEN IN PATIENTS WITH PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS |
Abstract in atti di convegno pubblicato in rivista |
Vai |
| 2017 |
Late onset of unilateral optic disk edema secondary to treatment with imatinib mesylate |
Articolo in rivista |
Vai |
| 2017 |
Acquired haemophilia in cancer: A systematic and critical literature review |
Review essay (rassegna critica) |
Vai |
| 2017 |
Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical hodgkin lymphoma and correlation with early FDG-PET assessment |
Articolo in rivista |
Vai |
| 2015 |
Comprehensive Geriatric Assessment is an essential tool to support treatment decisions in elderly patients with Diffuse Large B Cell Lymphoma: A prospective multicenter evaluation on 173 patients by the Lymphoma Italian Foundation (FIL) |
Articolo in rivista |
Vai |
| 2015 |
Absolute Lymphocyte Count Is Unrelated to Overall Survival in Newly Diagnosed Elderly Patients with Multiple Myeloma Treated with Immunomodulatory Drugs. |
Lettera |
Vai |
| 2015 |
Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: A Fondazione Italiana Linfomi phase II study |
Articolo in rivista |
Vai |
| 2015 |
A Case of Fatal Drug Rash Eosinophilia and Systemic Symptoms from Allopurinol |
Articolo in rivista |
Vai |
| 2014 |
Optimal Duration of Low Molecular Weight Heparin for the Treatment of
Cancer-Related Deep Vein Thrombosis: The Cancer-DACUS Study. |
Articolo in rivista |
Vai |
| 2014 |
Antiviral treatment in patients with indolent B-cell
lymphomas associated with HCV infection: a study
of the Fondazione Italiana Linfomi |
Articolo in rivista |
Vai |
| 2013 |
Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe |
Articolo in rivista |
Vai |
| 2013 |
Functional In Vitro Studies Of Buffy Coat Pooled Platelets Cryopreserved In Dimethyl-Sulphoxide With a New System |
Proceedings |
Vai |
| 2013 |
Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort |
Articolo in rivista |
Vai |
| 2012 |
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010 |
Articolo in rivista |
Vai |
| 2012 |
Thrombotic complications in paroxysmal nocturnal haemoglobinuria: a literature review. |
Articolo in rivista |
Vai |
| 2012 |
CANCER AS A PREDICTOR FOR INCREASED PERIPROCEDURAL BLEEDING DURING SURGERY OR PLATELET-INDUCED CHEMOTHERAPY IN CHRONICALLY ANTICOAGULATED PATIENTS |
Proceedings |
Vai |
| 2012 |
PREDICTORS OF RESIDUAL VEIN THROMBOSIS AFTER CANCER-RELATED DEEP VEIN
THROMBOSIS OF THE LOWER LIMBS |
Proceedings |
Vai |
| 2012 |
ABSOLUTE LYMPHOCYTE COUNT IS NOT A PREDICTOR FOR SURVIVAL IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA. FINAL RESULTS OF A MULTICENTER STUDY |
Proceedings |
Vai |
| 2012 |
ABSOLUTE LYMPHOCYTE COUNT IS NOT A PREDICTOR FOR SURVIVAL IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA |
Proceedings |
Vai |
| 2012 |
Genotypic resistance profiles associated with virological failure to darunavir-containing regimens: A cross-sectional analysis |
Articolo in rivista |
Vai |
| 2012 |
CD200 ANTIGEN IN B-CELL DERIVED NEOPLASMS: EXPRESSION AND CLINICAL IMPACT IN 77 CONSECUTIVE PATIENTS OF A SINGLE ISTITUTION |
Proceedings |
Vai |
| 2012 |
PNEUMOCYSTIS JIROVECI PNEUMONIA IN HEMATOLOGICAL PATIENTS:
A SINGLE INSTITUTION EXPERIENCE |
Proceedings |
Vai |
| 2011 |
Single-dose palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy containing steroids: results of a phase II study from the Gruppo Italiano per lo Studio dei Linfomi (GISL). |
Articolo in rivista |
Vai |
| 2011 |
LONG TERM RESULTS OF STANFORD V REGIMEN AND HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) IN 59 PATIENTS (PTS) WITH HD AND HIV INFECTION (HD-HIV) |
Proceedings |
Vai |
| 2011 |
ABSOLUTE LYMPHOCYTE COUNT AS PREDICTOR FOR SURVIVAL IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA |
Proceedings |
Vai |
| 2011 |
VEBEP REGIMEN IN PATIENTS (PTS) WITH HD AND HIV INFECTION(HD-HIV): FINAL RESULTS OF A PHASE II STUDY OF THE ITALIAN COOPERATIVE GROUP ON AIDS AND TUMORS (GICAT) |
Proceedings |
Vai |
| 2011 |
A novel methodology for large-scale phylogeny partition |
Articolo in rivista |
Vai |
| 2011 |
Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study |
Articolo in rivista |
Vai |
| 2011 |
A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen |
Articolo in rivista |
Vai |
| 2011 |
Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI |
Articolo in rivista |
Vai |
| 2011 |
Bendamustine with or without rituximab in the treatment of relapsed chronic lymphocytic leukaemia: an Italian retrospective study. |
Articolo in rivista |
Vai |
| 2011 |
No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failing antiretroviral therapy |
Articolo in rivista |
Vai |
| 2010 |
BENDAMUSTINE IN ASSOCIATION WITH RITUXIMAB AS SALVAGE THERAPY FOR SPLENIC MARGINAL ZONE LYMPHOMA |
Proceedings |
Vai |
| 2010 |
Low rate of virological failure and maintenance of susceptibility to HIV-1 protease inhibitors with first-line lopinavir/ritonavir-based antiretroviral treatment in clinical practice |
Articolo in rivista |
Vai |
| 2010 |
BENDAMUSTINE (B) IN COMBINATION WITH RITUXIMAB (R) FOR PATIENTS WITH RELAPSED/RESISTANT CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): AN ITALIAN MULTICENTRE RETROSPECTIVE STUDY |
Proceedings |
Vai |
| 2010 |
T Cell Large Granular Lymphocytic Leukemia in Association with Sjógren's Syndrome |
Articolo in rivista |
Vai |
| 2009 |
Bendamustin in association with Rituximab (BR) in the treatment of patients with relapsed/refractory lymphoid neoplasm. A GISL retrospective study |
Proceedings |
Vai |
| 2009 |
Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: Not All AIDS-defining conditions are created equal |
Articolo in rivista |
Vai |
| 2009 |
Pre-emptive treatment with cidofovir for Cytomegalovirus antigenemia in autologous bone marrow recipients and CLL patients on therapy with alemtuzumab |
Proceedings |
Vai |
| 2009 |
Lymphonodal amyloidosis: case report |
Proceedings |
Vai |
| 2009 |
Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting |
Articolo in rivista |
Vai |
| 2009 |
Chronic myeloid leukemia as second malignancy; a retrospective multicentrico study |
Proceedings |
Vai |
| 2009 |
Chronic myeloid leukemia as second malignancy; restrospective multicentric study |
Proceedings |
Vai |
| 2008 |
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction |
Articolo in rivista |
Vai |
| 2008 |
Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART |
Articolo in rivista |
Vai |
| 2008 |
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration |
Articolo in rivista |
Vai |
| 2008 |
Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): Analysis of the incidence of newly acquired hepatitis B infection and syphilis |
Articolo in rivista |
Vai |
| 2008 |
Screening sierologico per Leishmania infantum su donatori di sangue e HIV+ asintomatici residenti in area endemica [Serological screening for Leishmania infantum in asymptomatic blood donors and HIV+ patients living in an endemic area] |
Articolo in rivista |
Vai |
| 2008 |
Synthesis and induction of G0-G1 phase arrest with apoptosis of 3,5-dimethyl-6-phenyl-8-(trifluoromethyl)-5,6-dihydropyrazolo[3,4-f][1,2,3,5]tetrazepin-4(3H)-one |
Articolo in rivista |
Vai |
| 2007 |
E' la pneumocistosi ancora presente in pazienti HIV positivi in epoca HAART? |
Proceedings |
Vai |
| 2007 |
“Evidence of HIV-1 second-generation recombinant strains (SGRs) in Sicily: sequence analysis of gag, pol, and env genes.” |
Proceedings |
Vai |
| 2007 |
Dimagrimento e diarrea: oltre la "wasting syndrome" |
Articolo in rivista |
Vai |
| 2007 |
Synthesis and induction of G0-G1 phase arrest with apoptosis of 3,5-dimethyl-6-phenyl-8-trifluoromethyl-5,6-dihydropyrazolo[3,4-f][1,2,3,5]tetrazepin-4-one |
Proceedings |
Vai |
| 2007 |
Genetic diversity of HIV-1 non-B strains in Sicily: Evidence of intersubtype recombinants by Sequence Analysis of gag, pol, and env genes |
Articolo in rivista |
Vai |
| 2006 |
CASO CLINICO |
Altro |
Vai |
| 2006 |
INFEZIONE DA HIV E IMMIGRATI NEGLI ULTIMI CINQUE ANNI DI ATTIVITA' DEL NOSTRO CENTRO |
Proceedings |
Vai |
| 2006 |
LA TERAPIA DELL'HIV IN STADIO AVANZATO IN CORSO DI EPATITE CRONICA DA HCV |
Altro |
Vai |
| 2006 |
Screening sierologico per l'infantum in soggetti HIV+ in area endemica Sicilia occidentale |
Proceedings |
Vai |
| 2006 |
VALIDITA' DEL METODO DI IMMUNOFLUORESCENZA DIRETTA NELLA DIAGNOSI DI GIARDIASI IN UN SOGGETTO HIV+ |
Proceedings |
Vai |
| 2004 |
RICERCA DI GIARDIA, CRYPTOSPORIDIUM E ISOSPORA IN SOGGETTI HIV POSITIVI |
Altro |
Vai |
| 2004 |
Molecular epidemiology of HIV type 1 (HIV-1) non-B subtypes in SIcily |
Proceedings |
Vai |
| 2004 |
MOLECULAR EPIDEMIOLOGY OF HIV TYPE 1 (HIV-1) NON-B SUBTYPES IN SICILY |
Abstract in rivista |
Vai |
| 2004 |
Prevalence of Giardia, Cryptosporidium and Isospora in HIv-seropositive individuals in Sicily. |
Proceedings |
Vai |
| 2004 |
DETECTION OF HIV TYPE 1 (HIV-1) NON-B SUBTYPES IN SICILY, ITALY |
Articolo in rivista |
Vai |
| 2004 |
AIDS AND SURGICAL PATIENTS |
Altro |
Vai |
